Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

Healthcare Market Research in the Gulf: 3 lessons I’ve learned

A few key considerations for conducting healthcare market research in the Gulf

Inizio

Case study: Multiple Sclerosis new medical device research

Our client wanted to find out how best to develop an implantable delivery device technology with add-on services in the Multiple Sclerosis market. We were tasked with finding out whether such a...

Inizio

- PMLiVE

Martin Reeves joins Oxford BioDynamics

He takes up a senior vice president role

- PMLiVE

AlixPartners appoints new managing director

Dr Andreas Vogt takes up new role at the global business advisory firm

- PMLiVE

FDA approves Newron’s Parkinson’s disease drug Xadago

Becomes first new treatment licensed for the condition in over a decade

- PMLiVE

Havas brings consumer and professional health within one division

Havas Health & You will include agencies such as Health4Brands and Havas Lynx

- PMLiVE

AB Science claims first with motor neurone disease therapy

ALS patients on masitnib lived longer without their disease progressing

Getting the most out of your agency – a guide to developing a dynamic and rewarding relationship with your agency partner

A high proportion of pharma and biotech marketing budget is spent on medical communications agencies. In fact, over the years the size of this service industry has grown enormously and is...

Porterhouse Medical Group

- PMLiVE

Transforming B2B healthcare marketing

Why marketers should be creating engaging content in the B2B healthcare sector

Bone Therapeutics strengthens clinical development team

Dr Miguel Forte joins the firm as chief medical officer

- PMLiVE

Hookipa Biotech appoints new global head of research and development

Dr Igor Matushansky joins the firm from Daiichi Sankyo

Novartis day

Could Cosentyx free psoriasis patients from treatment?

One in five patients on the Novartis treatment remained symptom-free for a year

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links